These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 28498810)

  • 1. The prognostic value of GLUT1 in cancers: a systematic review and meta-analysis.
    Yu M; Yongzhi H; Chen S; Luo X; Lin Y; Zhou Y; Jin H; Hou B; Deng Y; Tu L; Jian Z
    Oncotarget; 2017 Jun; 8(26):43356-43367. PubMed ID: 28498810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinicopathologic impacts and prognostic significance of GLUT1 expression in patients with lung cancer: A meta-analysis.
    Zhang B; Xie Z; Li B
    Gene; 2019 Mar; 689():76-83. PubMed ID: 30552981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic role of glycolysis for cancer outcome: evidence from 86 studies.
    Yu M; Chen S; Hong W; Gu Y; Huang B; Lin Y; Zhou Y; Jin H; Deng Y; Tu L; Hou B; Jian Z
    J Cancer Res Clin Oncol; 2019 Apr; 145(4):967-999. PubMed ID: 30825027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Value of L-Type Amino Acid Transporter 1 (LAT1) in Various Cancers: A Meta-Analysis.
    Zhang C; Xu J; Xue S; Ye J
    Mol Diagn Ther; 2020 Oct; 24(5):523-536. PubMed ID: 32410110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of the combination of glucose transporter 1 and ATP citrate lyase in node-negative patients with non-small lung cancer.
    Osugi J; Yamaura T; Muto S; Okabe N; Matsumura Y; Hoshino M; Higuchi M; Suzuki H; Gotoh M
    Lung Cancer; 2015 Jun; 88(3):310-8. PubMed ID: 25837797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose transporter GLUT1 expression and clinical outcome in solid tumors: a systematic review and meta-analysis.
    Wang J; Ye C; Chen C; Xiong H; Xie B; Zhou J; Chen Y; Zheng S; Wang L
    Oncotarget; 2017 Mar; 8(10):16875-16886. PubMed ID: 28187435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological and prognostic significance of GLUT1 in breast cancer: A meta-analysis.
    Deng Y; Zou J; Deng T; Liu J
    Medicine (Baltimore); 2018 Nov; 97(48):e12961. PubMed ID: 30508885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA NEAT1 overexpression is associated with poor prognosis in cancer patients: a systematic review and meta-analysis.
    Yang C; Li Z; Li Y; Xu R; Wang Y; Tian Y; Chen W
    Oncotarget; 2017 Jan; 8(2):2672-2680. PubMed ID: 27926523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TIM-3 is a potential prognostic marker for patients with solid tumors: A systematic review and meta-analysis.
    Zhang Y; Cai P; Liang T; Wang L; Hu L
    Oncotarget; 2017 May; 8(19):31705-31713. PubMed ID: 28423646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic role of the long non-coding RNA, SPRY4 Intronic Transcript 1, in patients with cancer: a meta-analysis.
    Wang M; Dong X; Feng Y; Sun H; Shan N; Lu T
    Oncotarget; 2017 May; 8(20):33713-33724. PubMed ID: 28410241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Value of Melanoma-Associated Antigen-A (MAGE-A) Gene Expression in Various Human Cancers: A Systematic Review and Meta-analysis of 7428 Patients and 44 Studies.
    Poojary M; Jishnu PV; Kabekkodu SP
    Mol Diagn Ther; 2020 Oct; 24(5):537-555. PubMed ID: 32548799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of glucose transporter 1 (GLUT1) in the diagnosis and therapy of tumors].
    Jóźwiak P; Lipińska A
    Postepy Hig Med Dosw (Online); 2012 Jan; 66():165-74. PubMed ID: 22470192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GLUT1 and ASCT2 as Predictors for Prognosis of Hepatocellular Carcinoma.
    Sun HW; Yu XJ; Wu WC; Chen J; Shi M; Zheng L; Xu J
    PLoS One; 2016; 11(12):e0168907. PubMed ID: 28036362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic and clinicopathological significance of circulating tumor cells detected by RT-PCR in non-metastatic colorectal cancer: a meta-analysis and systematic review.
    Yang C; Zou K; Zheng L; Xiong B
    BMC Cancer; 2017 Nov; 17(1):725. PubMed ID: 29115932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of glucose transporter 1 and prognosis in non-small cell lung cancer: a pooled analysis of 1665 patients.
    Tan Z; Yang C; Zhang X; Zheng P; Shen W
    Oncotarget; 2017 Sep; 8(37):60954-60961. PubMed ID: 28977837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA HOTTIP as an independent prognostic marker in cancer.
    Fan Y; Yan T; Chai Y; Jiang Y; Zhu X
    Clin Chim Acta; 2018 Jul; 482():224-230. PubMed ID: 28778381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validity and clinical impact of glucose transporter 1 expression in colorectal cancer.
    GabAllah GMK; El-Din Habib MS; Soliman SE; Kasemy ZA; Gohar SF
    Saudi J Gastroenterol; 2017; 23(6):348-356. PubMed ID: 29205188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of TSP-1 as prognostic marker in various cancers: a systematic review and meta-analysis.
    Sun S; Dong H; Yan T; Li J; Liu B; Shao P; Li J; Liang C
    BMC Med Genet; 2020 Jun; 21(1):139. PubMed ID: 32600280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of GLUT1 in colorectal cancer is independently associated with poor prognosis.
    Shen YM; Arbman G; Olsson B; Sun XF
    Int J Biol Markers; 2011; 26(3):166-72. PubMed ID: 21786248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of glucose transporter 1 on primary lesions of esophageal squamous cell carcinoma is associated with hematogenous recurrence.
    Sawayama H; Ishimoto T; Watanabe M; Yoshida N; Baba Y; Sugihara H; Izumi D; Kurashige J; Baba H
    Ann Surg Oncol; 2014 May; 21(5):1756-62. PubMed ID: 24242681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.